• Profile

Focal therapy eligibility determined by MRI/US fusion biopsy

The Journal of Urology Aug 24, 2017

Nassiri N et al. – This study assessed the eligibility for focal therapy (FT) in men who receive multiparametric magnetic resonance imaging (mpMRI) and targeted biopsy, with correlation to whole mount histology following radical prostatectomy (RP). The authors concluded that using intermediate–risk eligibility criteria, more than one third of men in whom targeted biopsy–proven lesion was identified on mpMRI would be eligible for FT. In addition, 75% of the cases showed concordant findings for eligibility determined by fusion biopsy and whole mount histology. However, improved selection criteria are required to reliably determine eligibility for FT.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen